2008
Evaluation and management of bone disease and fractures post transplant
Bia M. Evaluation and management of bone disease and fractures post transplant. Transplantation Reviews 2008, 22: 52-61. PMID: 18631858, DOI: 10.1016/j.trre.2007.09.001.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsBone diseasePost transplantTransplant recipientsFracture riskBone densitySolid organ transplant recipientsLow bone mineral densityEarly post transplantBone mineral density measurementsLow bone turnoverRecipients of kidneysOrgan transplant recipientsNonpharmacologic treatment strategiesBone mineral densityVitamin D analogsMineral density measurementsBisphosphonate therapySteroid dosesLung transplantPretransplant periodRenal osteodystrophyTransplant populationBone turnoverMineral density
2002
Treatment of Osteoporosis and Osteopenia in Long‐term Renal Transplant Patients with Alendronate
Cruz DN, Brickel HM, Wysolmerski JJ, Gundberg CG, Simpson CA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ. Treatment of Osteoporosis and Osteopenia in Long‐term Renal Transplant Patients with Alendronate. American Journal Of Transplantation 2002, 2: 62-67. PMID: 12095058, DOI: 10.1034/j.1600-6143.2002.020111.x.Peer-Reviewed Original ResearchConceptsBone mineral densityHigh bone turnoverRenal transplant patientsBone lossBone turnoverTransplant patientsTotal femurLumbar spineLong-term renal transplant patientsLong-term renal transplant recipientsBiochemical markersBiochemical parametersGood renal functionGroup A patientsRenal transplant recipientsBone turnover markersRegional bone mineral densityTreatment of osteoporosisSerum alkaline phosphataseFirst yearBisphosphonate therapyTransplant recipientsAlendronate therapyRenal functionA patients